Comparison of perioperative and short-term outcomes between robotic and conventional laparoscopic surgery for colonic cancer: a systematic review and meta-analysis.
10.4174/astr.2016.90.6.328
- Author:
Sungwon LIM
1
;
Jin Hee KIM
;
Se Jin BAEK
;
Seon Hahn KIM
;
Seon Heui LEE
Author Information
1. National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea.
- Publication Type:Comparative Study ; Meta-Analysis ; Original Article
- Keywords:
Robotic surgical procedures;
Colonic neoplasms
- MeSH:
Colon*;
Colonic Neoplasms*;
Defecation;
Diet;
Flatulence;
Humans;
Laparoscopy*;
Length of Stay;
Odds Ratio;
Robotic Surgical Procedures
- From:Annals of Surgical Treatment and Research
2016;90(6):328-339
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Reports from several case series have described the feasibility and safety of robotic surgery (RS) for colonic cancer. Experience is still limited in robotic colonic surgery, and a few meta-analysis has been conducted to integrate the results for colon cancer specifically. We conducted a systematic review of the available evidence comparing the surgical safety and efficacy of RS with that of conventional laparoscopic surgery (CLS) for colonic cancer. METHODS: We searched English databases (MEDLINE, Embase, and Cochrane Library), and Korean databases (KoreaMed, KMbase, KISS, RISS, and KisTi). Dichotomous variables were pooled using the risk ratio, and continuous variables were pooled using the mean difference (MD). RESULTS: The present study found that the RS group had a shorter time to resumption of a regular diet (MD, -0.62 days; 95% CI, -0.97 to -0.28), first passage of flatus (MD, -0.44 days; 95% CI, -0.66 to -0.23) and defecation (MD, -0.62 days; 95% CI, -0.77 to -0.47). Also, RS was associated with a shorter hospital stay (MD, -0.69 days; 95% CI, -1.12 to -0.26), a lower estimated blood loss (MD, -19.49 mL; 95% CI, -27.10 to -11.89) and a longer proximal margin (MD, 2.29 cm; 95% CI, 1.11-3.47). However, RS was associated with a longer surgery time (MD, 51.00 minutes; 95% CI, 39.38-62.62). CONCLUSION: We found that the potential benefits of perioperative and short-term outcomes for RS than for CLS. For a more accurate understanding of RS for colonic cancer patients, robust comparative studies and randomized clinical trials are required.
